SCARNA22 and Miyoshi myopathy: The slopes of the relationships between cell number and dose (Table 1, P = 0.33), and proliferation and dose (Table 1, P = 0.32) of melphalan were not different between MM overexpressing ACA11 and control, suggesting that ACA11 does not modify the response to melphalan at the doses tested here.